# A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male Volunteers

> **NCT03378284** · PHASE1 · COMPLETED · sponsor: **HK inno.N Corporation** · enrollment: 16 (actual)

## Conditions studied

- Pharmacodynamics
- Healthy Male Volunteers

## Interventions

- **DRUG:** Tegoprazan
- **DRUG:** Revaprazan

## Key facts

- **NCT ID:** NCT03378284
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-10
- **Primary completion:** 2017-12-23
- **Final completion:** 2018-01-16
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03378284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03378284, "A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03378284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*